G1 Therapeutics, Inc. (GTHX) Net Income (Loss) Attributable to Parent USD 2015 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
G1 Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • G1 Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$10.2 M, a 63% increase year-over-year.
  • G1 Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$30.6 M, a 75.7% increase year-over-year.
  • G1 Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$48 M, a 67.5% increase from 2022.
  • G1 Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$148 M, a 0.54% increase from 2021.
  • G1 Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$148 M, a 49.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$48 M +$99.6 M +67.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$148 M +$793 K +0.54% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$148 M -$49.1 M -49.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$99.3 M +$23.2 M +18.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$122 M -$37.2 M -43.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 -$85.3 M -$25.2 M -41.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 -$60.1 M -$29.8 M -98.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$30.3 M -$10 M -49.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$20.3 M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.